251 related articles for article (PubMed ID: 34333394)
1. Discovery of the first chemical tools to regulate MKK3-mediated MYC activation in cancer.
Yang X; Fan D; Troha AH; Ahn HM; Qian K; Liang B; Du Y; Fu H; Ivanov AA
Bioorg Med Chem; 2021 Sep; 45():116324. PubMed ID: 34333394
[TBL] [Abstract][Full Text] [Related]
2. Computer-aided drug discovery of Myc-Max inhibitors as potential therapeutics for prostate cancer.
Carabet LA; Lallous N; Leblanc E; Ban F; Morin H; Lawn S; Ghaidi F; Lee J; Mills IG; Gleave ME; Rennie PS; Cherkasov A
Eur J Med Chem; 2018 Dec; 160():108-119. PubMed ID: 30326371
[TBL] [Abstract][Full Text] [Related]
3. OncoPPi-informed discovery of mitogen-activated protein kinase kinase 3 as a novel binding partner of c-Myc.
Ivanov AA; Gonzalez-Pecchi V; Khuri LF; Niu Q; Wang Y; Xu Y; Bai Y; Mo X; Prochownik EV; Johns MA; Du Y; Khuri FR; Fu H
Oncogene; 2017 Oct; 36(42):5852-5860. PubMed ID: 28628118
[TBL] [Abstract][Full Text] [Related]
4. Development of a Time-Resolved Fluorescence Resonance Energy Transfer Ultrahigh-Throughput Screening Assay for Targeting the NSD3 and MYC Interaction.
Xiong J; Pecchi VG; Qui M; Ivanov AA; Mo X; Niu Q; Chen X; Fu H; Du Y
Assay Drug Dev Technol; 2018; 16(2):96-106. PubMed ID: 29634317
[TBL] [Abstract][Full Text] [Related]
5. A novel inhibitor L755507 efficiently blocks c-Myc-MAX heterodimerization and induces apoptosis in cancer cells.
Singh A; Kumar A; Kumar P; Nayak N; Bhardwaj T; Giri R; Garg N
J Biol Chem; 2021 Jul; 297(1):100903. PubMed ID: 34157284
[TBL] [Abstract][Full Text] [Related]
6. Discovery of a novel small-molecule inhibitor of Fam20C that induces apoptosis and inhibits migration in triple negative breast cancer.
Zhao R; Fu L; Yuan Z; Liu Y; Zhang K; Chen Y; Wang L; Sun D; Chen L; Liu B; Zhang L
Eur J Med Chem; 2021 Jan; 210():113088. PubMed ID: 33316691
[TBL] [Abstract][Full Text] [Related]
7. Scaffold Repurposing of In-House Small Molecule Candidates Leads to Discovery of First-in-Class CDK-1/HER-2 Dual Inhibitors: In Vitro and In Silico Screening.
Elkamhawy A; Ammar UM; Paik S; Abdellattif MH; Elsherbeny MH; Lee K; Roh EJ
Molecules; 2021 Sep; 26(17):. PubMed ID: 34500757
[TBL] [Abstract][Full Text] [Related]
8. Fragment-based drug discovery of potent and selective MKK3/6 inhibitors.
Adams M; Kobayashi T; Lawson JD; Saitoh M; Shimokawa K; Bigi SV; Hixon MS; Smith CR; Tatamiya T; Goto M; Russo J; Grimshaw CE; Swann S
Bioorg Med Chem Lett; 2016 Feb; 26(3):1086-1089. PubMed ID: 26704264
[TBL] [Abstract][Full Text] [Related]
9. Discovery of pyrazolo[3,4-d]pyrimidines as novel mitogen-activated protein kinase kinase 3 (MKK3) inhibitors.
Takarada JE; Cunha MR; Almeida VM; Vasconcelos SNS; Santiago AS; Godoi PH; Salmazo A; Ramos PZ; Fala AM; de Souza LR; Da Silva IEP; Bengtson MH; Massirer KB; Couñago RM
Bioorg Med Chem; 2024 Jan; 98():117561. PubMed ID: 38157838
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic Inhibition of Myc in Cancer. Structural Bases and Computer-Aided Drug Discovery Approaches.
Carabet LA; Rennie PS; Cherkasov A
Int J Mol Sci; 2018 Dec; 20(1):. PubMed ID: 30597997
[TBL] [Abstract][Full Text] [Related]
11. Activated MKK3/MYC crosstalk impairs dabrafenib response in BRAFV600E colorectal cancer leading to resistance.
Pranteda A; Piastra V; Serra M; Bernardini R; Lo Sardo F; Carpano S; Diodoro MG; Bartolazzi A; Milella M; Blandino G; Bossi G
Biomed Pharmacother; 2023 Nov; 167():115480. PubMed ID: 37713993
[TBL] [Abstract][Full Text] [Related]
12. Gossypetin is a novel MKK3 and MKK6 inhibitor that suppresses esophageal cancer growth in vitro and in vivo.
Xie X; Liu K; Liu F; Chen H; Wang X; Zu X; Ma X; Wang T; Wu Q; Zheng Y; Bode AM; Dong Z; Kim DJ
Cancer Lett; 2019 Feb; 442():126-136. PubMed ID: 30391783
[TBL] [Abstract][Full Text] [Related]
13. Discovery of novel pyruvate dehydrogenase kinases inhibitors by screening of an in-house small molecule library for anti-lung cancer therapeutics.
Guo F; Zhao S; Li X
Bioorg Med Chem Lett; 2019 Jan; 29(2):291-296. PubMed ID: 30470491
[TBL] [Abstract][Full Text] [Related]
14. Structure-based discovery of potent and selective small-molecule inhibitors targeting signal transducer and activator of transcription 3 (STAT3).
Huang Q; Zhong Y; Li B; Ouyang S; Deng L; Mo J; Shi S; Lv N; Wu R; Liu P; Hu W; Zhang X; Wang Y
Eur J Med Chem; 2021 Oct; 221():113525. PubMed ID: 34000483
[TBL] [Abstract][Full Text] [Related]
15. Discovery of novel CBP bromodomain inhibitors through TR-FRET-based high-throughput screening.
Zhang FC; Sun ZY; Liao LP; Zuo Y; Zhang D; Wang J; Chen YT; Xiao SH; Jiang H; Lu T; Xu P; Yue LY; Du DH; Zhang H; Liu CP; Luo C
Acta Pharmacol Sin; 2020 Feb; 41(2):286-292. PubMed ID: 31253937
[TBL] [Abstract][Full Text] [Related]
16. EDITORIAL: Advances in Developing Versatile Tools for the Discovery of Novel Therapeutics.
Hu Y
Curr Top Med Chem; 2017; 17(20):2233-2234. PubMed ID: 28799501
[No Abstract] [Full Text] [Related]
17. Turning Up the Heat on MYC: Progress in Small-Molecule Inhibitors.
Truica MI; Burns MC; Han H; Abdulkadir SA
Cancer Res; 2021 Jan; 81(2):248-253. PubMed ID: 33087323
[TBL] [Abstract][Full Text] [Related]
18. A cell competition-based small molecule screen identifies a novel compound that induces dual c-Myc depletion and p53 activation.
Tadele DS; Robertson J; Crispin R; Herrera MC; Chlubnová M; Piechaczyk L; Ayuda-Durán P; Singh SK; Gedde-Dahl T; Fløisand Y; Skavland J; Wesche J; Gjertsen BT; Enserink JM
J Biol Chem; 2021; 296():100179. PubMed ID: 33303632
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis and structure-activity relationship of a focused library of β-phenylalanine derivatives as novel eEF2K inhibitors with apoptosis-inducing mechanisms in breast cancer.
Guo Y; Zhao Y; Wang G; Chen Y; Jiang Y; Ouyang L; Liu B
Eur J Med Chem; 2018 Jan; 143():402-418. PubMed ID: 29202403
[TBL] [Abstract][Full Text] [Related]
20. Discovery of a potent dual ALK and EGFR T790M inhibitor.
Jang J; Son JB; To C; Bahcall M; Kim SY; Kang SY; Mushajiang M; Lee Y; Jänne PA; Choi HG; Gray NS
Eur J Med Chem; 2017 Aug; 136():497-510. PubMed ID: 28528303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
